Product Name | Reversine |
Description |
A3 adenosine receptor antagonist |
Purity | >98% (HPLC/TLC); NMR (conforms) |
CAS No. | 656820-32-5 |
Molecular Formula | C21H27N7O |
Molecular Weight | 393.5 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Antagonist |
Solubility | May be dissolved in DMSO (7 mg/ml) |
Source | Synthetic |
Appearance | Off-white powder |
SMILES | C1CCC(CC1)NC2=NC(=NC3=C2NC=N3)NC4=CC=C(C=C4)N5CCOCC5 |
InChI | InChI=1S/C21H27N7O/c1-2-4-15(5-3-1)24-20-18-19(23-14-22-18)26-21(27-20)25-16-6-8-17(9-7-16)28-10-12-29-13-11-28/h6-9,14-15H,1-5,10-13H2,(H3,22,23,24,25,26,27) |
InChIKey | ZFLJHSQHILSNCM-UHFFFAOYSA-N |
Safety Phrases |
This product does not require a Material Safety Data Sheet under the Occupational Safety and Health Administration standard entitled "Hazard Communication" 29 CFR 1910.1200 for the United States. The product does not meet the criteria of W.H.M.I.S. classification as a controlled product. As a result, a W.H.M.I.S. Material Safety Data Sheet is not required (in Canada) for this product. |
Cite This Product | Reversine (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-564) |
Alternative Names | 2-(4-Morpholinoanilino)-6-cyclohexylaminopurine, Reversine; 656820-32-5; CHEMBL188343; CHEBI:70723; IN1127 |
Research Areas | Autophagy, Cancer, Cancer Growth Inhibitors, Cardiac Metabolism, Cardiovascular System, Cell Signaling, G Protein Signaling, GPCR, Heart, Mesenchymal Stem Cells, mTOR Inhibitors, Stem Cells, Tumor suppressors |
PubChem ID | 210332 |
Reviews
There are no reviews yet.